Psychological treatment of social anxiety disorder: a meta-analysis. by Acarturk, C. et al.
Psychological treatment of social anxiety
disorder: a meta-analysis
C. Acarturk1,*, P. Cuijpers1,2, A. van Straten1 and R. de Graaf2
1 Vrije Universiteit University Amsterdam, Department of Clinical Psychology, Amsterdam, The Netherlands
2 Trimbos Institute (Netherlands Institute of Mental Health and Addiction), Utrecht, The Netherlands
Background. Older meta-analyses of the eﬀects of psychological treatments of social anxiety disorder have found
that these treatments have moderate to large eﬀects. However, these earlier meta-analyses also included non-
randomized studies, and there are many featured studies in this area which were published after the recent meta-
analysis.
Method. We conducted a systematic literature search and identiﬁed 29 randomized studies examining the eﬀects
of psychological treatments, with a total of 1628 subjects. The quality of studies varied. For the analyses, we used the
computer program COMPREHENSIVE META-ANALYSIS (version 2.2.021 ; Biostat, Englewood, NJ, USA).
Results. The mean eﬀect size on social anxiety measures (47 contrast groups) was 0.70, 0.80 on cognitive measures
(26 contrast groups) and 0.70 both on depression (19 contrast groups) and general anxiety measures (16 contrast
groups). We found some heterogeneity, so we conducted a series of subgroup analyses for diﬀerent variables of
the studies. Studies with waiting-list control groups had signiﬁcantly larger eﬀect sizes than studies with placebo
and treatment-as-usual control groups. Studies aimed at subjects who met Diagnostic and Statistical Manual of
Mental Disorders (DSM) criteria for social anxiety disorder had smaller eﬀect sizes than studies in which other
inclusion criteria were used.
Conclusions. This study once more makes it clear that psychological treatments of social anxiety disorder are
eﬀective in adults, but that they may be less eﬀective in more severe disorders and in studies in which care-as-usual
and placebo control groups are used.
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Introduction
Social anxiety disorder is a highly prevalent disorder
(Davidson et al. 1993 ; Kessler et al. 1994; Bijl et al.
1998 ; Furmark, 2002 ; Grant et al. 2005) and is asso-
ciated with losses in quality of life (Stein et al. 2000 ;
Wittchen et al. 2000), considerable economic costs
(Patel et al. 2002 ; Smit et al. 2006), high levels of ser-
vice use (Magee et al. 1996 ; Stein & Kean, 2000) and
serious functional impairments in the educational,
social and occupational domains (Davidson et al.
1993 ; Kessler et al. 1998). In order to decrease the
burden on individuals with social anxiety disorder,
several psychological treatments have been devel-
oped in the past few decades (Deacon & Abramowitz,
2004 ; Rodebaugh et al. 2004), including exposure,
cognitive therapy, social skills training, applied relax-
ation, and several diﬀerent combinations of these.
The eﬀects of these psychological treatments on
social anxiety disorder have been examined in a
considerable number of trials since the late 1970s
(Fremouw & Zitter, 1978 ; Shaw, 1979). Throughout
this period, studies changed from small and uncon-
trolled trials (Heimberg et al. 1985) to large, high-
quality randomized controlled trials (Blomhoﬀ et al.
2001). In order to examine and compare the eﬃcacy
of these treatments some narrative reviews were con-
ducted (Heimberg, 1989 ; Chambless & Gillis, 1993).
However, it was not possible with those reviews
to quantify their eﬀects on social anxiety disorder.
Subsequently, four meta-analyses that examined
the eﬀects of psychological treatments were pub-
lished. The ﬁrst compared the eﬀects of cognitive
behavioural therapy to exposure alone (Feske &
Chambless, 1995). A little later, Taylor (1996) exam-
ined the eﬀectiveness of cognitive behavioural treat-
ments (exposure, cognitive restructuring without
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exposure, exposure with cognitive restructuring, and
social skills training) on social anxiety disorder. In
1997, Gould et al. (1997) added the pharmacological
studies to cognitive behavioural treatments and com-
pared these two treatment approaches. The last meta-
analysis was similar in design to the previous one
(Federoﬀ & Taylor, 2001) and examined the psycho-
logical and pharmacological treatments of social
anxiety disorder.
These meta-analyses showed that both psychologi-
cal and pharmacological interventions are eﬀective
in the treatment of social phobia and have large eﬀect
sizes. All of them indicated that cognitive behav-
ioural therapies were eﬀective. However, they found
somewhat diﬀerent results concerning the superiority
of speciﬁc interventions. Feske & Chambless (1995)
reported that there is no additional beneﬁt of com-
bining exposure and cognitive interventions over
exposure therapy alone. Conversely, Taylor (1996)
found that the eﬀects of exposure can be increased
with cognitive therapy. In line with Feske &
Chambless (1995), Gould et al. (1997) reported that
exposure had a higher eﬀect size than the combi-
nation of exposure with cognitive restructuring
(cognitive restructuring alone had the lowest eﬀect
size). Although all of the earlier meta-analyses in-
dicated that exposure is eﬀective, the contribution
of cognitive therapy seems to be a matter of debate.
However, a possible explanation for this was re-
ported in the review of Deacon & Abramowitz
(2004) ; there are fewer trials with only cognitive
therapy without any behavioural element. Therefore,
to make a more strong comparison between cognitive
therapies and exposure, the literature needs more
studies with treatment conditions with cognitive
therapies only.
On the other hand, pharmacological treatments of
social anxiety disorder were also found to be eﬀec-
tive. Although the most recent meta-analysis found
that pharmacological treatments of social anxiety dis-
order were the most eﬀective treatments at least in
the short-term (Blomhoﬀ et al. 2001 ; Federoﬀ &
Taylor, 2001; Clark et al. 2003 ; Davidson et al. 2004),
there is a lack of studies that directly compare the
eﬀects of psychological and pharmacological treat-
ments, so we can not make a clear comparison be-
tween them.
However, these previous meta-analyses suﬀer
from several limitations (Rodebaugh et al. 2004). Most
of them also included non-randomized and uncon-
trolled studies, which may have resulted in an over-
estimation of the eﬀects. The one meta-analysis that
did focus on randomized trials was conducted more
than 10 years ago, and since then 14 new studies
have been published that were not included in this
meta-analysis. Another important shortcoming of
earlier meta-analyses is that none of them conducted
state-of-the-art analyses of the heterogeneity of the
included studies, nor did they conduct subgroup
analyses or meta-regression analyses to examine the
sources of heterogeneity. Such analyses are important
because they may indicate which diﬀerences among
the studies aﬀect the outcomes (Rodebaugh et al.
2004) and may also indicate which treatments are
eﬀective in which populations.
We decided, therefore, to conduct a new meta-
analysis with 14 new studies, which is about half of
the included studies. We wanted to examine whether
the positive results of the earlier meta-analyses re-
main positive when limited to randomized trials and
when all new studies in this area are included. We
also wanted to study the heterogeneity of the studies
and examine which characteristics of the studies are
related to the eﬀect sizes.
Method
Identiﬁcation and selection of studies
Several methods were used to ﬁnd the studies. First,
we conducted a comprehensive literature search in
bibliographical databases (from 1966 to January
2007). We examined 1820 abstracts in Pubmed (301
abstracts), PsycINFO (232), EMBASE (682) and the
Cochrane Central Register of Controlled Trials (414).
In order to ﬁnd unpublished studies, we also
searched Digital Dissertations (191 abstracts). We
searched these databases by combining terms that are
indicative of psychological treatment (psychotherapy,
mental health treatment, psychological treatment,
cognitive therapy, behavior therapy, exposure, social
skills training, ﬂooding, and relaxation) and social
phobia (or social anxiety disorder). Second, we
examined the references of the earlier meta-analyses
(Feske & Chambless, 1995 ; Taylor, 1996 ; Gould et al.
1997 ; Fedoroﬀ & Taylor, 2001) and systematic re-
views (Deacon & Abramowitz, 2004 ; Rodebaugh
et al. 2004). Third, we examined the references of
the retrieved papers. No language restrictions were
applied.
We included studies in which (1) the eﬀects of
psychological treatments (2) in subjects aged 18 years
or older (3) with social phobia (4) were compared
with a control condition (5) in a randomized con-
trolled trial.
We included studies which used one of the follow-
ing deﬁnitions : (1) social anxiety disorder according
to Diagnostic and Statistical Manual of Mental
Disorders (DSM)-III (APA, 1980), DSM-III-R (APA,
1987) or DSM-IV (APA, 1994) criteria ; (2) scoring
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above a cut-oﬀ score on a self-rating or clinician-rated
social anxiety disorder questionnaire (Table 1).
Although to include studies with diﬀerent criteria
might cause heterogeneity, we did not want to ex-
clude valuable randomized controlled trials. We
aimed to solve possible heterogeneity problems by
conducting subgroup analysis.
Quality assessment
The validity and quality of the studies were assessed
according to the Cochrane Handbook (Higgins &
Green, 2005). The four basic criteria were : allocation
to conditions is done by an independent (third)
party ; adequacy of random allocation concealment to
respondents ; blinding of assessors of outcomes ; and
completeness of follow-up data.
Meta-analysis
We calculated eﬀect size (Cohen’s d) by subtracting
(at post-test) the average score of the control group
(Mc) from the average score of the experimental
group (Me) and dividing the result by the average of
the standard deviations of the experimental and con-
trol group (S.D.ec ; Hedges & Olkin, 1985 ; Cooper &
Hedges, 1994). An eﬀect size of 0.5 thus shows that
the mean of the experimental group is half a stan-
dard deviation larger than the mean of the control
group. Eﬀect sizes of 0.56–1.2 can be assumed to be
large, while eﬀect sizes of 0.33–0.55 are moderate,
and eﬀect sizes of 0–0.32 are small (Lipsey & Wilson,
1993).
Eﬀect sizes were calculated only from reliable and
valid self-rated or observer-rated questionnaires.
When means and standard deviations were not re-
ported, we used other statistics (t value, p value) for
the calculation of eﬀect sizes. When more than one
measure was used, we calculated the mean of the
eﬀect sizes for each study. In the studies that com-
pared more than one experimental condition with a
control condition, the number of subjects in the con-
trol condition was evenly divided over the exper-
imental conditions so that each subject was used only
once in the meta-analyses.
We calculated four eﬀect sizes for each study:
one measuring social anxiety disorder, another one
measuring cognitive distortions, one of depression,
and one measuring general anxiety.
The COMPREHENSIVE META-ANALYSES computer pro-
gram (version 2.2.021 ; Biostat, Englewood, NJ, USA)
was used to calculate the pooled mean eﬀect sizes.
Because of the considerable heterogeneity, we calcu-
lated the mean eﬀect sizes with the random-eﬀects
model. In the random-eﬀects model, it is assumed
that the included studies are from populations of
studies that diﬀer from each other systematically. In
the random-eﬀects model, the eﬀect sizes diﬀer be-
cause of the random error within the studies but also
because of true variation in eﬀect size from one study
to the next.
As indicator of homogeneity, we calculated the Q
statistics. A signiﬁcant Q rejects the null hypothesis
of homogeneity and indicates that the variability
among the eﬀect sizes is greater than what is likely
to have resulted from subject-level sampling error
alone. We also calculated the I2 statistic, which is an
indicator of heterogeneity in percentages. A value of
0% indicates no observed heterogeneity, and larger
values show increasing heterogeneity, with 25% as
low, 50% as moderate, and 75% as high heterogen-
eity (Higgins et al. 2003). Moreover, speciﬁc methods
for subgroup analyses in the COMPREHENSIVE META-
ANALYSIS version 2.2.021 were also conducted to see
whether their eﬀect sizes diﬀer from each other.
Publication bias was tested by inspecting the
funnel plot on primary outcome measures (eﬀects on
social anxiety at post-test), and by Duval & Tweedie’s
trim and ﬁll procedure (Duval & Tweedie, 2000),
which yields an estimate of the eﬀect size after the
publication bias has been taken into account (as im-
plemented in COMPREHENSIVE META-ANALYSIS, version
2.2.021). We also calculated ‘Orwin’s fail-safe N ’.
This number indicates how many studies with an
eﬀect size of zero should be found in order to reduce
the eﬀect size that is found to a smaller value (e.g.
0.20). A larger N indicates that the eﬀect size found
can be further generalized.
Results
Description of studies
A total of 109 papers that possibly met our inclusion
criteria were retrieved for further study. A total of
80 studies were excluded: four because the assign-
ment to the conditions was not random; eight were
excluded because the interventions were not psycho-
logical treatments ; and four were excluded because
of their clinically irrelevant diagnostic criteria. More-
over, 41 studies had no control group, three studies
gave insuﬃcient data to calculate the eﬀect size,
ﬁfteen studies were not aimed only at patients with
social anxiety disorder but also with other anxiety
disorders, and ﬁve studies reported data identical to
a later study published by the same authors. A total
of 29 publications with 30 studies (with 49 separate
controlled comparisons) that met inclusion criteria
were included in this meta-analysis (Fig. 1). Charac-
teristics of these 30 studies are described in Table 1.
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Table 1. Characteristics of randomized controlled studies examining the eﬀects of psychological treatments on social phobia
First-
named
author
(year) Country
Age
groups
(years)
Target population
Type
of SP Conditions
Subjects
(n)
Intervention
(number of sessions) Format
Follow-
up Instrument
DO
(%)
ITT/
CO
Recruit-
ment Diagnosis
Akillas
(1995)
USA 18–41
(University
students)
Com DSM III-R+
SADo11
1. Symptom
prescription
without
reframing
15 Prescribed the performance of
speciﬁc behaviour without
logical explanation (3)
IND Pre, post,
1 month
SAD, FNE,
STAIT-T, BDI
NR NR
2. Symptom
prescription
with reframing
16 Prescribed the performance of
speciﬁc behaviour with
logical explanation (3)
IND
3. Waiting list 16
Andersson
(2006)
EU 18–67 Com DSM-IV+SCID (SP-primary)+
SPSQ+MADRS-S< 31 on
depression and<4 on suicide
items
1. CBT
(Internet)+two
in vivo groups
30 CBT : self-help manual to
describe SP and its
symptoms, according
to CBT (9)
IND+
two
GRPs
Pre, post,
12 months
LSAS, SPS, SIAS,
SPSQ, PRCS/BAI,
MADR
3.1 ITT
2. Waiting list 32
Ayres
study I
(1993)
USA University
students
Com Scored 1 S.D.
or more above the mean of
PRCA compared with the
population of interest
PS 1. Video for
PS anxiety
17 Systematic desensitisation
(1)
GRP Pre, post PRCA, negative
thoughts (%)
7.1 CO
2. Placebo group 18 Film : how to give a speech (1) GRP
3. Control group 17 No treatment
Ayres
study II
(1993)
USA University
students
Com Scored 1 S.D.
or more above the mean of
PRCA compared with the
population of interest
PS 1. Video for
PS anxiety
30 Systematic desensitization
(1)
IND Pre, post,
6 months
PRCA, negative
thoughts %)
15.5 CO
2. Placebo group 30 Film : how to give a speech (1) IND
3. Control group 30 No treatment
Blomhoof
(2001)
EU 18–65 Clin+
Com
DSM-IV+CGI-SPSo4 GSP 1. Exposure/
placebo
91 Homework, symptom-
monitoring diary, and
new coping strategies (9)
IND Pre, post BSPS, FQ- SP,
FNE, SPS
7.4 ITT
2. Placebo 88
Butler
(1984)
EU 18–65 Clin DSM-III (SP), Scale
of Phobic Severityo4
GSP 1. Exposure
without AM
15 Exposure without managing
anxiety (7)
IND Pre, post,
6 months
SAD, FNE 8.1 CO
2. Waiting list 15 Associative therapy : how
to see the problem
objectively (7)
IND
Clark
(2006)
EU 18–60 Clin DSM-IV (SP) 1. CT 21 CT : restructuring distorted
self-imagery, video
feedback (14)
IND Pre, post,
3 and 12
months
SPC, SIAS, LSAS,
SPAI-SP, SPWSS,
FNE, BAI, BDI
3.2 ITT
2. Exposure
+AR
21 Exposure+AR: exposure,
realization training, homework,
in vivo exercises (14)
IND3. Waiting list
20
Clark
(1991)
EU 18–60 Com DSM-III-R (SCID),
PRCPo8
Performance
anxiety
1. CBT+placebo 7 CBT : cognitive distortions,
coping, exposure (5)
GRP Pre, post,
1 month
PRCS, FNE, SAD,
SSQ
14.7 CO
2. Placebo 7
Cunningham
(2006)
USA NR, adults,
mean age
42.6
Com Moderate fear of
PSo5, no other
social fears
PS 1. The Lefkoe
method
17 De-condition the stimuli that
produce fear (2–5)
IND Pre, post SUBSS, PRCS 10.0 CO
2. Waiting list 19
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Davidson
(2004)
USA 18–65 Clin DSM-IV : GSP GSP 1. Compre-
hensive
CBT
60 Comprehensive CBT : in vivo
exposure, CR, SST
GRP Pre, post BSPS, SPAI, 28.0 ITT
2. Placebo 59
Fremouw
(1978)
USA 18–24 Com Upper quartile (o80)
of PRCA+o16 PRCS
PS 1. Skills training 12 Skills training : modelling,
rehearsal and video
feedback (5)
GRP Pre, post,
2 months
PRCS, SAD, PRCA 0 ITT
2. Cognitive
restructuring –
relaxation 12 CRT : muscle relaxation,
identify and replace negative
self-state (5)
GRP
3. Waiting list 11
Gruber
(2001)
USA 25–60 Com ADIS-R : SP
(according to DSM-III-R)
1. CBGT 14 CBGT (12) GRP Pre, post,
6 months
FNE, BDI, SPAI,
SPS, SISST/
14.8 CO
2. CBGT+
CaCBGT
15 CBGT+CaCBGT : cognitive
preparation+ cognitive
debrieﬁng (8)
GRP
3. Waiting
list
17
Harvey
(2000)
EU University
students
Com Top 25% (o17) and
bottom 25% (f9) of the
FNE+< 20 on BDI
1. CP 20 CP : predict before viewing the
video and form an image of
themselves and then watch
it as a stranger (1)
IND Pre, post PS, CAWS, BCS 0 ITT
2. No CP 20 IND
Haynes-
Clements
(1984)
USA University
students
Com o10 on the SSI 1. SST 12 SST : cognitive processes and
behavioural skills to maximize
social interaction (6)
GRP Pre, post SAD, FNE, ASBT 0 ITT
2. Waiting list 12
Heimberg
(1998)
USA 18–65 Clin DSM-III-R SP 1. CBGT 28 CBGT : automatic thought,
logical errors, formulation of
rational responses (12)
GRP Pre, post SAD, FNE, FQ-SP,
SIAS, SPS, SCL-90
R anxiety,
depression
54.2 CO
2. Matching
placebo
27
Hofmann
(2004)
USA o18 Clin DSM-IV SP+o4
on a self-report for PS
PS 1. CBGT 26 CBGT : skills to identify negative
cognitions (12)
GRP Pre, post,
6 months
SPAI, SCQ 22.5 CO
2. EGT 24
3. Waiting
list
19 EGT : in-session in vivo
exposure (12)
GRP
Jerremalm
(1986)
EU 20–60 Clin Major problem anxiety
in a wide range of social
situations
1. AR 10 AR : tension- release of the
muscles, role- playing (11)
IND Pre, post FSS-III, APQ,
SSQ, TI, BDI
16.2 CO
2. SIT 10
3. Waiting list 18 SIT : stress-inoculation training
without relaxation part (11)
IND
Kanter
(1979)
USA 22–52 Com Deﬁnition of SP 1. Systematic
rational
restructuring
15 SRR : imagery training,
homework (7)
GRP Pre, post,
9 weeks
SAD, FNE, IBT,
STAI-T
16.2 CO
2. SCD 13 SCD: imagery training and
desensitisation (7)
GRP
3. SCD+SRR 18
GRP
4. Waiting list 16
Mattick
(1989)
Aus Mean
age 41
Com+
Clin
DSM-III SP 1. GE 11 GE : graded approach (6) GRP Pre, post,
3 months
SIAS, FQ, FNE,
SPS, IBT
9.4 CO
2. CR with
exposure
11 GE+CR: to use cognitive
techniques during
exposure (6)
GRP
3. GE+CR 11
GRP
4. Waiting list 10
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Table 1 (cont.)
First-
named
author
(year) Country
Age
groups
(years)
Target population
Type
of SP Conditions
Subjects
(n)
Intervention
(number of sessions) Format
Follow-
up Instrument
DO
(%)
ITT/
CO
Recruit-
ment Diagnosis
Mersch
(1995)
EU 18–60 Com DSM-III-R SP 1. Exposure
in vivo
7 Exposure (14) IND Pre, post,
3 and 18
months
FNE, FQ, SIB, IBI,
SASSI-N
16.6 CO
2. IT 7 IT : RET, SST, exposure (14)
3. Waiting list 16
Mo¨rtberg
(2006)
EU <65 Clin DSM-IV SP (SCID) GSP/non-
GSP
1. ICBGT 13 ICBGT : psycho-education,
CR, AR, homework,
video-recorded
exposure (9)
GRP Pre, post,
3 and 6
months
LSAS, SPS, BDI,
SIAS, FNE, SIDL,
SBQ
7.6 CO
2. Waiting list 13
Mo¨rtberg
(2007)
EU 18–65 Com DSM-IV SP 1. IGCT 26 IGCT : psycho-education,
AR (16)
GRP Pre, post,
8 and
12 months
FNE, FQ, BR, LSAS,
SIAS, SPS, BDI, NC,
SPWSS
28.0 ITT
2. ICT 28
ICT : shorter sessions for
4 months,
individual model (16)
IND3. TAU 18
TAU : SSRI with psychiatric care IND
Newman
(1994)
USA Mean age
46.5
Com. DSM-III-R SP
(SCID)+speech
anxietyo7/10
PS 1. Exposure 15 ET : pure performance based
(without cognitive
intervention) (8)
GRP Pre, post PRCS, SAD, SPAI,
FNE, CT, STAI-T
8.3 CO
2. Waiting list 17
Oosterbaan
(2001)
USA 18–65 Com+
Clin
DSM-III-R SP
(SCID)
1. CT 24 CT : cognitive restructuring,
based on the theory of
Beck (12)
IND Pre, post,
2 and
15 months
FQ, ISS, LSAS, SCI,
MADRS
22.0 CO
2. Placebo 19
Salaberria
(1998)
EU 18–54 Clin+
Com
DSM-III-R SP (ADIS-R),
o15 SAD oro21 FNE
GSP 1. Self-exposure
in vivo
24 Self-exposure in vivo : break
avoidance (8)
GRP Pre, post,
1, 3, 6 and
12 months
SAD, FNE, BDI 23.0 CO
2. Self-exposure
in vivo and CT
24 Self-exposure in vivo with CT :
exposure with questioning
irrational thoughts (8)3. Waiting list 23 GRP
Schelver
(1983)
USA University
students
Com o13 on SADS+interpersonal
anxiety for minimum of 1 year
1. CT 11 Book – RET (Ellis & Harper,
1975)
IND Pre, post SAD, FNE, STAI-T 22.2 CO
2. Control group 12 No treatment
Smits
(2006)
USA 18–51 Com DSM-IV SP (CIDI-Auto) PS 1. Exposure+
video feed of
performance
19 Video feed of
performance (3)
Reaction of
audience (3)
IND
Pre, post,
1 month
LSAS 12.0 CO
2. Exposure+
video feed
of audience
20
No feedback (3)
Information about
beta-wave
activity
IND
3. Only
exposure
23
IND
4. Placebo 15
IND
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Stangier
(2003)
EU 18–65 Clin+
Com
DSM-IV SP
(SCID)
1. CBGT 22 More in-session
experiment (15)
GRP Pre, post,
6 months
SPAI, SPS, SIAS,
BDI, BAI, SCL
8.5 ITT
2. CBT 22
Clark & Wells’ model (15)
IND
3. Waiting list 21
Stravynski
(2000)
CN Adults Com+
Clin
DSM-IV SP
(ADIS)
1. IR with SST 28 Developing interpersonal
skill (14)
IND Pre, post,
6 and 12
months
FQ, SAD,
FNE, SCL
90 depression,
anxiety
11.7 CO
2. IR without SST 32
Practice of target
behaviour (14)3. Waiting list 21
IND
Turner
(1994)
USA 18–56 Clin DSM-III-R SP
(ADIS-R)
1. Flooding 26 Imaginal and in vivo
ﬂooding (20)
IND
Pre, post,
6 months
SPAI 12.1 CO
2. Placebo drug 21 Beta-blocking drug
Identical appearance
with atenol
SP, Social phobia ; DO, drop-outs ; ITT, intention to treat ; CO, completers ; Com, community ; DSM, Diagnostic and Statistical Manual of Mental Disorders ; SAD, Social Avoidance and Distress Scale ; IND,
individual ; FNE, Fear of Negative Evaluation ; STAIT-T, State-Trait Anxiety Inventory-Trait ; BDI, Beck Depression Inventory ; NR, not reported ; EU, European Union ; SCID, Structured Clinical Interview for
Psychiatric Disorders ; SPSQ, Social Performance Scale Questionnaire ; MADRS-S, Montgomery–A˚sberg Depression Rating Scale – Self-rated ; CBT, cognitive behavioural therapy ; GRP, group ; LSAS, Liebowitz
Social Anxiety Scale ; PRCS, Personal Report on Conﬁdence as a speaker ; BAI, Beck Anxiety Inventory ; MADR, Montgomery–A˚sberg Depression Rating ; S.D, standard deviation ; PRCA, Personal Report of
Communication Apprehension ; PS, public speaking phobia ; Clin, clinical ; CGI-SPS, Clinical Global Impression – Social Phobia Scale ; GSP, generalized social phobia ; BSPS, Brief Social Phobia Scale ; FQ-SP,
Fear Questionnaire Social Phobia Scale ; AM, anxiety management ; CT, cognitive therapy ; AR, applied relaxation ; SPS, Social Phobia Scale ; SPAI-SP, Social Phobia and Anxiety Inventory – social phobia ;
SPWSS, Social Phobia Weekly Summary Scale ; PRCP, Personal Report of Conﬁdence as a Performer ; SSQ, Self-Statement Questionnaire ; SUBSS, Subjective Units of Bothersome Sensations Scale ; CRT,
cognitive relaxation therapy ; SST, social skills training ; ADIS-R, Anxiety Disorders Inventory Schedule–Revised ; CBGT, cognitive behavioural group therapy ; CaCBGT, computer-assisted cognitive
behavioural group therapy ; SISST, Social Interactions Self-Statement Test ; CP, cognitive preparation ; CAWS, Coming Across Well Score ; BCS, Behaviors Composite Score ; ASBT, Assessment of Self-Statement
and Behavior Test ; SCL-90 R, Symptom Checklist 90 Revised ; EGT, exposure group therapy ; SPAI, Social Phobia and Anxiety Inventory ; SCQ, Social Cognitions Scale ; SIT, Stress Inoculation Training ; FSS-III,
Fear Survey Schedule III ; APQ, Autonomic Perception Questionnaire ; TI, Thought Index ; SCD, self-control desensitization ; SRR, Systematic Rational Restructuring ; IBT, Irrational Beliefs Test ; STAIT,
State-Trait Anxiety Inventory ; Aus, Australia ; GE, guided exposure ; CR, cognitive restructuring ; FQ, Fear Questionnaire ; IT, integrated treatment ; RET, rational emotive therapy ; SIB, Scale for Interpersonal
Behavior ; IBI, Irrational Beliefs Inventory ; SASSI-N, Social Anxiety Self-Statements Inventory-negative ; ICBGT, intensive cognitive behavioural group therapy ; IGCT, intensive group cognitive therapy ; SIDL,
Symptoms’ Inﬂuence on Daily Life Scale ; SBQ, Social Behaviors Questionnaire ; ICT, individual cognitive therapy ; TAU, treatment as usual ; SSRI, selective serotonin reuptake inhibitor ; BR, Belief Rating ; NC,
Negative Cognitions ; CT, Cognitions during the Talk scale ; STAI-T, State Trait Anxiety Inventory - trait ; IIS, Inventory of Interpersonal Situations ; SCI, Social Cognitions Inventory ; MADRS,
Montgomery–Asberg Depression Rating Scale ; SADS, Social Avoidance and Distress Scale ; CIDI-Auto, Composite International Diagnostic Interview ; SCL, Symptom Checklist ; CN, Canada ; ADIS, Anxiety
Disorders Inventory Schedule ; IR, interpersonal relations.
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The studies included a total of 1628 respondents
(979 in the treatment conditions and 649 in the con-
trol conditions). Selected characteristics of the in-
cluded studies are described in Table 1. In 16 studies,
subjects were recruited from the community, whereas
in eight studies subjects were recruited from clinical
settings. In the remaining six studies, a mixed recruit-
ment method was reported. Seven studies focused on
university students, while the remaining 23 studies
were aimed at adults in general. In 21 studies the
subjects had to meet diagnostic criteria for social anx-
iety disorder. The remaining nine studies included
subjects who scored high on self-rating social anxiety
measures, or used another deﬁnition of social anxiety
disorder. In 14 comparisons, the psychological treat-
ment was delivered in individual format, while in 15
comparisons a group format was used (in one study,
group and individual formats were combined). The
number of sessions varied between one and 20. The
exclusive psychological treatments were cognitive be-
havioural therapy (14 conditions), cognitive therapy
(four conditions), social skills training (three con-
ditions), relaxation (two conditions), exposure (eight
conditions), and other therapies such as symptom
prescription with or without reframing, and the
Lefkoe method. The Lefkoe method aims to eliminate
the beliefs that are formed a long time ago by empha-
sizing the earlier circumstances. It also de-conditions
the stimuli that produce negative emotions such as
fear (Cunningham et al. 2006). In the remaining con-
ditions, various combinations of those psychological
treatments were applied (Table 1). In 22 studies,
psychological treatments were compared with a wait-
ing-list control group, while in seven studies a pla-
cebo control group was used; in the remaining study,
a treatment-as-usual control group was used.
The quality of the 30 studies varied. Only in four
studies was allocation to conditions conducted by an
independent party. Concealment of random allo-
cation to respondents was not possible or not re-
ported in any of the studies. Twelve studies reported
blinding of assessors, and drop-out rates ranged from
0 to 54.2% (in one study the drop-out rate was not
reported). Intention-to-treat analyses were used only
in a minority of the studies (n=9) while the majority
of the studies (n=20) were limited to completers-
only analyses (not reported in one study).
Eﬀects of psychological treatments at post-test
The eﬀects of psychological treatments on social
anxiety measures could be compared with a control
group in 29 studies with 48 contrast groups. The
mean eﬀect size for measures of social anxiety
disorder was 0.77 [95% conﬁdence interval (CI)
0.60–0.94, Table 2]. In two studies, the psychological
treatments were combined with placebo (Clark, 1991 ;
Blomhoﬀ et al. 2001). To check for possible diﬀer-
ences, we conducted a meta-analysis without those
two studies. The results were comparable (0.80, 95%
CI 0.64–0.97, Q=82.8, p<0.001, I2=45.6%) with the
results when those two studies were included. Thus,
we continued to include them in the following analy-
sis. Heterogeneity was moderate (Q=101.1, p<0.001,
I2=53.5%), so we decided to check for the outliers.
One study with an unusually high eﬀect size
(Cunningham et al. 2006) was considered as an out-
lier, and excluded from all further analyses. The
mean eﬀect size for the remaining 47 contrast groups
was 0.70 (95% CI 0.56–0.83). The heterogeneity was
considerably lower (Q=65.6, p<0.01, I2=29.8%). We
have plotted the eﬀect sizes and 95% CIs of the com-
parisons in Fig. 2.
In eighteen studies (26 contrast groups), the fear of
negative evaluation (FNE; Watson & Friend, 1969)
was used as an outcome measure. In a meta-analysis
in which the results were limited to FNE, comparable
results were found (d=0.59, 95% CI 0.39–0.78,
Q=42.94, p<0.01, I2=41.7%), as was the case when
we examined the eﬀect sizes on the Social Avoidance
and Distress Scale (Watson & Friend, 1969 ; 11 stud-
ies, 15 comparisons ; d=0.83, 95% CI 0.56–1.10,
Q=21.33, p<0.05, I2=34.4%).
1820 Abstracts
•  301 Pubmed
•  232 PsycINFO
Retrieved
109 
80 Excluded 
• no control group (41)
• include not only 
subjects with SAD (15) 
• not psychological
intervention (8)
• reported previous data
(5)
• clinically irrelevant
diagnosis (4)
• no random assignment
(4)
• insufficient data to
calculate effect size (3) 
1820 Abstracts 
 •  301 Pubmed
 •  232 PsycINFO
 •  682 EMBASE
 •  414 Cochrane
Fig. 1. Selection and inclusion of studies. SAD, Social
anxiety disorder.
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We conducted three more meta-analyses ; for
cognitive outcomes, depression, and general anxiety
measurements. We could compare the eﬀects of the
psychological treatments with a control group at
post-test on cognitive measurements in 15 studies
with 26 contrast groups (Table 2). The mean eﬀect
size for cognitive measures was 0.80 (95% CI 0.54–
1.05, Q=54.0, p<0.001, I2=53.7%). For self-report
measures of depression, we were able to compare 12
studies with 19 contrast groups, which resulted in a
mean eﬀect size of 0.70 (95% CI 0.46–0.94, Q=36.7,
p<0.01, I2=50.9%). We compared the eﬀects of
the psychological treatments on general anxiety
measures at post-test in nine studies with 16 contrast
groups. The mean eﬀect size was 0.70 (95% CI 0.47–
0.93, Q=19.6, N.S., I2=23.2%).
Table 2. Meta-analyses of studies examining the eﬀects of psychological treatments on social phobia (with subgroup analyses), cognitive,
and depression/anxiety measures compared with control conditions at post-test : overall results and subgroup analyses
No. of
contrast
groups d 95% CI Q I2 (%) p
Overall eﬀects
All studies 48 0.769 0.60–0.94 101.13*** 53.52
One study excluded 47 0.698 0.56–0.83 65.55* 29.83
Only one condition 28 0.594 0.44–0.75 41.51* 34.96
FNEa 26 0.585 0.39–0.78 42.94* 41.78
SADb 15 0.830 0.56–1.10 21.33 N.S. 34.37
Cognitive 26 0.796 0.54–1.05 54.03*** 53.73
Depression 19 0.700 0.46–0.94 36.72* 50.99
General anxiety 16 0.700 0.47–0.93 19.55 N.S. 23.27
Subgroup analyses
Control group Waiting list 35 0.860 0.72–1.00 35.89 N.S. 5.26 ***
Placebo+TAU 12 0.360 0.20–0.52 8.86 N.S. 0.0
Age groups Student sample 7 1.057 0.74–1.37 9.39 N.S. 36.11 N.S.
Adults 40 0.578 0.46–0.69 48.40 N.S. 19.42
Type of social
phobia
General 36 0.611 0.49–0.73 51.57* 32.14 N.S.
Speciﬁc 11 0.732 0.48–0.98 13.25 N.S. 24.55
Format Individual 23 0.614 0.47–0.76 46.42* 52.61 N.S.
Group 24 0.652 0.50–0.81 19.01 N.S. 0.0
Diagnosis DSM 35 0.569 0.45–0.69 46.52 N.S. 26.91 **
Not DSM 12 0.980 0.71–1.25 11.63 N.S. 5.42
Recruitment Community 22 0.725 0.55–0.90 22.07 N.S. 4.87 N.S.
Clinical/community 25 0.578 0.44–0.71 41.78*** 42.56
CBT CBT 24 0.708 0.56–0.85 35.79* 35.74 N.S.
Non-CBT 23 0.546 0.39–0.70 27.57 N.S. 20.21
Exposure Exposure 8 0.794 0.50–1.09 2.34 N.S. 0 N.S.
No exposure 39 0.607 0.49–0.72 61.84*** 38.55
Relaxation Relaxation 8 0.552 0.26–0.85 3.35 N.S. 0 N.S.
No relaxation 39 0.645 0.53–0.76 61.87* 38.58
Social skills
training
Social skills training 8 0.833 0.60–1.06 13.10 N.S. 46.55 N.S.
No social skills training 39 0.576 0.46–0.70 48.67 N.S. 21.92
Analyses Intention to treat 13 0.448 0.29–0.60 24.96* 51.92 N.S.
Completers only 32 0.803 0.65–0.95 28.30 N.S. 0
Follow-up
1–3 months 20 0.190 0.02–0.36 15.88 N.S. 0.0
4–6 months 12 0.371 0.12–0.63 19.19 N.S. 42.66
7–18 months 16 0.148 0.01–0.29 9.23 N.S. 0.0
CI, Conﬁdence interval ; FNE, fear of negative evaluation ; SAD, Social Avoidance and Distress Scale ; N.S., non-signiﬁcant ;
TAU, treatment as usual ; DSM, Diagnostic and Statistical Manual of Mental Disorders ; CBT, cognitive behavioural therapy.
a Only the eﬀects on the FNE were included in this meta-analysis.
b Only the eﬀects on the SAD were included in this meta-analysis.
* p<0.05 ; ** p<0.01, *** p<0.001.
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Study name
(year) Outcome
Statistics for each study
S.D. in means and 95% CI
S.D.
in means S.E.
Lower
limit
Upper
limitVariance Z p
Akillas (1995) I
Akillas (1995) II
Andersson (2006)
Ayres (1993) I
Ayres (1993) II
Clark (2006) I
Clark (2006) II
Fremouw (1978) I
Fremouw (1978) II
Gruber (2001) I
Gruber (2001) II
Haynes (1984)
Hofmenn (2004) I
Hofmenn (2004) II
Kanter (1979) I
Kanter (1979) II
Kanter (1979 III
Mattick (1989) I
Mattick (1989) II
Mattick (1989) III
Mersch (1995) I
Mersch (1995) II
Mörtberg (2006)
Newman (1994)
Selaberria (1998) I
Selaberria (1998) II
Schelver (1983) I
Schelver (1983) II
Smits (2006) I
Smits (2006) II
Smits (2006) III
Stangier (2003) I
Stangier (2003) II
Stravynski (2000) I
Stravynski (2000) II
Turner (1994)
Blomhoff (2001)
Clark (1991)
Davidson (2004) I
Davidson (2004) II
Mörtberg (2007) I
Mörtberg (2007) I
Jerremelm (1986) I
Jerremelm (1986) II
Heimberg (1998)
Oosterbaan (2001)
Butler (1984) I
Combined 0.233 0.439 0.193 –0.628 1.095
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
Combined
1.133 0.463 0.214 0.225 2.041
0.710 0.263 0.069 0.195 1.224
0.789 0.357 0.127 0.090 1.488
1.754 0.344 0.118 1.080 2.428
1.967 0.470 0.221 1.046 2.889
0.851 0.407 0.166 0.053 1.649
0.638 0.515 0.265 –0.371 1.647
0.179 0.501 0.251 –0.803 1.162
1.149 0.460 0.211 0.248 2.051
0.708 0.390 0.152 –0.055 1.472
1.395 0.456 0.208 0.502 2.288
0.820 0.385 0.148 0.066 1.574
0.505 0.381 0.145 –0.242 1.252
1.404 0.564 0.318 0.298 2.510
0.718 0.540 0.291 –0.340 1.777
1.015 0.527 0.278 –0.018 2.049
0.897 0.688 0.474 –0.451 2.246
0.734 0.687 0.472 –0.612 2.081
0.996 0.698 0.487 –0.371 2.364
0.669 0.534 0.286 –0.378 1.717
0.362 0.523 0.274 –0.663 1.388
0.560 0.416 0.173 –0.256 1.376
0.727 0.367 0.135 0.008 1.447
1.282 0.431 0.186 0.436 2.127
1.298 0.432 0.186 0.452 2.144
1.065 0.540 0.291 0.007 2.123
0.652 0.512 0.262 –0.351 1.656
LSAS
0.561 0.512 0.262 –0.443 1.565LSAS
0.190 0.510 0.260 –0.809 1.189
LSAS 0.572 0.513 0.263 –0.433 1.576
0.104 0.370 0.137 –0.621 0.828
0.289 0.372 0.138 –0.440 1.017
1.186 0.391 0.153 0.420 1.952
1.539 0.409 0.167 0.737 2.341
SPAI 0.930 0.329 0.108 0.285 1.575
0.090 0.150 0.022 –0.203 0.384
0.100 0.536 0.287 –0.950 1.149
0.583 0.228 0.052 0.136 1.029
0.562 0.228 0.052 0.115 1.009
0.253 0.297 0.088 –0.330 0.836
0.419 0.303 0.092 –0.175 1.014
a1 0.360 0.570 0.325 –0.757 1.477
b1 0.870 0.630 0.397 –0.365 2.105
0.326 0.280 0.078 –0.223 0.874
0.318 0.309 0.096 –0.288 0.924
0.748 0.378 0.143 0.008 1.488
Random 0.698
–4.00 –2.00 0.00 2.00 4.00
Control Treatment
0.531 0.595
2.446 0.014
2.702 0.007
2.212 0.027
5.101 0.000
4.186 0.000
2.091 0.037
1.240 0.215
0.358 0.720
2.500 0.012
1.818 0.069
3.061 0.002
2.132 0.033
1.324 0.185
2.489 0.013
1.331 0.183
1.925 0.054
1.304 0.192
1.069 0.285
1.428 0.153
1.253 0.210
0.693 0.488
1.346 0.178
1.981 0.048
2.972 0.003
3.007 0.003
1.973 0.048
1.274 0.203
1.095 0.273
0.373 0.709
1.115 0.265
0.281 0.779
0.776 0.437
3.035 0.002
3.762 0.000
2.828 0.005
0.604 0.546
0.186 0.853
2.558 0.011
2.463 0.014
0.851 0.395
1.383 0.167
0.632 0.528
1.381 0.167
1.164 0.244
1.028 0.304
1.980 0.048
0.069 0.005 0.562 0.833 10.093 0.000
Fig. 2. Standardized eﬀect sizes of psychological treatments compared with control conditions at post-test. S.D., Standard diﬀerence ; S.E., standard error ; CI, conﬁdence interval ;
LSAS, Liebowitz Social Anxiety Scale ; SPAI, Social Phobia and Anxiety Inventory.
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We have included multiple comparisons from one
study in our analyses. However, these multiple com-
parisons are not independent from each other, and
this may result in an artiﬁcial reduction of hetero-
geneity. Therefore, we conducted an additional meta-
analysis, in which we included only one comparison
per study. From the studies with multiple com-
parisons we included only the comparison with the
smallest eﬀect size, because this was considered
the most conservative approach in estimating hetero-
geneity. As can be seen in Table 2, these analyses
did indicate that heterogeneity increased somewhat,
although the increase was relatively small.
Subgroup analyses
Because we found some heterogeneity, we decided
to conduct a series of subgroup analyses for control
group (waiting list versus placebo/treatment-as-
usual), type of analysis (intention-to-treat versus
completers only), diagnosis (according to diagnostic
criteria versus scoring above a cut-oﬀ score or another
measure of social anxiety disorder), age group (uni-
versity students versus adults), type of social anxiety
disorder (generalized social anxiety versus speciﬁc
social anxiety disorder), format of intervention
(individual versus group intervention), recruitment
(volunteers from the community versus clinical popu-
lation/both), and type of psychological interventions.
We distinguished between interventions in which
cognitive restructuring was included versus interven-
tions in which this was not included. We also dis-
tinguished interventions in which exposure was and
was not included; and interventions in which social
skills training was and was not included. The results
of the analyses are presented in Table 2.
The subgroup analyses resulted in only two
subgroups of studies in which the eﬀects sizes
diﬀered signiﬁcantly from each other. Studies with
waiting-list control groups had a signiﬁcantly larger
eﬀect size than studies with placebo or treatment-
as-usual control groups. Furthermore, studies aimed
at subjects who met diagnostic criteria for a social
anxiety disorder had a smaller eﬀect size than
studies in which other inclusion criteria were used.
These two pairs of subgroups also had low to
moderate levels of heterogeneity (I2 in waiting-list
control group=5.26 ; in placebo/treatment-as-usual=
0.0 ; in studies in which diagnostic criteria were
used=26.91 ; in studies in which another deﬁnition
of social anxiety disorder was used=5.42).
Eﬀects at follow-up
It was not possible to calculate the eﬀects of psy-
chological interventions compared with a control
condition at follow-up in any study, because most
studies used a waiting-list control condition. Instead,
we calculated the eﬀect sizes indicating the diﬀerence
between post-test and follow-up in the treatment
conditions. We could calculate these eﬀect sizes in
20 studies. The follow-up periods ranged from
1 month to 18 months and the eﬀect sizes ranged
from x0.022 (at 6 months follow-up) to 2.32 (at
1 month follow-up).
In 10 studies with 20 conditions, the follow-up
period was between 1 and 3 months. The resulting
pooled random eﬀect size was 0.19 (95% CI 0.02–
0.36), indicating a small and a signiﬁcant improve-
ment from post-test to follow-up. Eight studies with
12 contrast groups also showed a signiﬁcant change
from post-test to 4 to 6 months (d=0.37, 95% CI 0.12–
0.63). The change between post-test and 7 to 18
months follow-up could also be calculated in nine
studies with 16 contrast groups, and resulted in a
pooled eﬀect size of 0.15 (95% CI 0.01–0.29), which is
a small improvement. These results indicate that
the eﬀects of the psychological interventions on social
anxiety disorder probably remain stable over time
and may even improve somewhat.
Publication bias
The funnel plot and Duval & Tweedie’s trim and ﬁll
procedure pointed at the possibility of some publi-
cation bias. The eﬀect size indicating the diﬀerence
in social anxiety between treatment and control con-
ditions did not change signiﬁcantly after adjustment
for possible publication bias (observed d=0.70, 95%
CI 0.56–0.83 ; adjusted d=0.45, 95% CI 0.30–0.60 ;
both with the random-eﬀects model). However, the
adjusted value was considerably lower than the ob-
served values, so one must be very careful about a
possible overestimation of the mean eﬀect size. The
number of studies with a zero eﬀect that should be
found in order to reduce the eﬀect size to 0.20 is 102
(‘Orwin’s fail-safe N ’). This large number of unpub-
lished null trials led us to conclude that the present
ﬁndings were unlikely to be biased by the ‘ﬁle-
drawer ’ problem.
Discussion
This study showed that a meta-analysis of random-
ized studies of psychological treatments of social
anxiety disorder conﬁrms the ﬁndings of earlier
meta-analyses that supported the eﬀectiveness of
various kinds of psychological treatments of social
anxiety disorder in adults (Feske & Chambless, 1995 ;
Taylor, 1996 ; Gould et al. 1997; Federoﬀ & Taylor,
2001). The present ﬁndings are important because
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almost half of the included studies were not used in
the earlier meta-analyses. The overall eﬀect size of
0.70 indicated a large eﬀect of psychological treat-
ments on social anxiety disorder. However, a small
to moderate heterogeneity (I2=29.8%) in our meta-
analyses pointed at some possible systematic diﬀer-
ences among the included studies. Since one of
the aims of this study was to explore the sources
of heterogeneity, we conducted several subgroup
analyses.
Subgroup analyses indicated that studies with pill-
placebo or treatment-as-usual control groups had
lower eﬀect sizes than the ones with waiting-list con-
trol groups. The low heterogeneity of the two sub-
groups indicated that the overall heterogeneity of
the present meta-analysis may be explained by the
diﬀerent control groups of the studies. Additionally,
subgroup analyses also indicated that studies which
included subjects meeting diagnostic criteria for a
social anxiety disorder had signiﬁcantly lower eﬀect
sizes than the studies that used other inclusion cri-
teria. Heterogeneity was zero to low in these sub-
groups, which may indicate that this diﬀerence in
diagnostic inclusion criteria may explain the hetero-
geneity in the overall analyses. In other words, the
heterogeneity which is troublesome could be reduced
if the researchers include only the studies which
were conducted with the subjects who fulﬁll the
diagnostic criteria for social anxiety disorder. Also,
these results point at the possibility that social anxi-
ety disorder can be treated better in patients with
milder problems, and that treatment is more diﬃcult
in patients with more severe disorders. More re-
search is needed to examine this.
We also found that studies in which a waiting-list
control group was used had signiﬁcantly higher ef-
fect sizes than studies with a care-as-usual or placebo
control group, and in both subgroups very low levels
of heterogeneity were found. This is in agreement
with other research in other treatment areas where
waiting-list control groups typically ﬁnd higher eﬀect
sizes (Cuijpers et al. 2007).
We found no indication in our subgroup analyses
that the inclusion of cognitive restructuring, ex-
posure, social skills training, or applied relaxation
resulted in higher eﬀect sizes. However, most studies
used a mix of several of these methods and very few
studies examined only one of these techniques. This
makes it impossible to draw deﬁnite conclusions
about the eﬀects of each of these techniques. More
research and especially dismantling studies are
needed to explore the speciﬁc eﬀect of each of these
techniques in more detail.
We found one outlier in our meta-analysis, with
an unusually high eﬀect size (Cunningham et al.
2006). It is not entirely clear why this study had
this unusual eﬀect size, but it diﬀers from other
studies in that it uses a very speciﬁc method (the
Lefkoe method). It could be possible that this is a
very eﬀective intervention for social speaking anxi-
ety. However, before this can be established, more
studies conﬁrming these very high eﬀect sizes should
be conducted.
This study has several limitations. First, although
our meta-analysis included a relatively large number
of studies, we did not have suﬃcient studies to
examine more speciﬁc subgroups, such as studies
with care-as-usual, placebo control groups, and
studies in which subjects were recruited from clinical
samples. Second, the quality of several studies was
not optimal, and most studies conducted completers-
only analysis instead of intention-to-treat analyses.
Despite these limitations, the present meta-analysis
suggests that psychological treatments are eﬀective
in treating social anxiety disorder in adults, and this
eﬀect tends to remain stable to follow-up and may
even improve somewhat. Although the number of
studies on psychological treatment of social anxiety
disorder is relatively high, more research is deﬁnitely
needed. More research on clinical samples is needed,
as well as research in which pill-placebo and treat-
ment-as-usual are used as the control groups. Pref-
erably, these should be high-quality studies with
large sample sizes. In order to examine the active
components of the psychological treatments, disman-
tling studies should be conducted.
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